T. Rowe Price Associates’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.09M | Sell |
|
|||||
|
2025
Q2 | $17.3M | Sell |
|
|||||
|
2025
Q1 | $24.7M | Sell |
|
|||||
|
2024
Q4 | $50.2M | Sell |
|
|||||
|
2024
Q3 | $48.7M | Sell |
|
|||||
|
2024
Q2 | $44.7M | Buy |
|
|||||
|
2024
Q1 | $39M | Sell |
|
|||||
|
2023
Q4 | $45.4M | Buy |
|
|||||
|
2023
Q3 | $47.4M | Buy |
|
|||||
|
2023
Q2 | $44.5M | Sell |
|
|||||
|
2023
Q1 | $43.3M | Sell |
|
|||||
|
2022
Q4 | $40.8M | Buy |
|
|||||
|
2022
Q3 | $46.8M | Buy |
|
|||||
|
2022
Q2 | $29.7M | Sell |
|
|||||
|
2022
Q1 | $23.4M | Buy |
|
|||||
|
2021
Q4 | $34.6M | Buy |
|